Evaluating the Experience of Diagnosis in Parkinson’s Disease
Objective: To evaluate a newly-designed diagnosis patient pathway for Parkinson’s disease, in terms of quality measures and patient satisfaction. Background: Receiving a diagnosis of Parkinson’s…Efficacy of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson’s disease: results from the Phase 3 study dose-titration phase
Objective: To determine the dose of APL-130277 required by each patient with Parkinson’s Disease (PD) to turn from OFF to Full ON. This dose is…Intensive Short-Term Dance Intervention in Parkinson’s Disease
Objective: To evaluate changes in motor symptoms and quality of life for people with Parkinson’s disease (PD) as a result of an intensive short-term dance intervention. …Multi-modal retention in a phase III clinical trial in early Parkinson disease (STEADY-PD III)
Objective: To evaluate novel retention strategies in an ongoing phase 3 clinical trial in individuals with Parkinson disease (PD) Background: Adequate participant retention is a…Associating patient impression of improvement with efficacy endpoints in Parkinson’s disease: A post-hoc analysis of a tozadenant study
Objective: To evaluate whether patient perceived improvement of Parkinson’s disease (PD) symptoms was associated with improvement in efficacy endpoints (mean daily OFF time and ON…99mTc-TRODAT-1 SPECT imaging in early and late onset Parkinson’s disease.
Objective: In this study we tried to determine the TRODAT SPECT findings in EOPD as compared to LOPD. Background: 99mTc-TRODAT-1, which binds to the dopamine…The effect of expectation on Parkinson’s Disease: an EEG study
Objective: The aim of the present study is to determine how the expectation of receiving a therapeutic treatment influences Parkinson’s disease (PD) symptoms. Background: The…The prevalence of cerebral microbleeds in patients with Parkinson’s disease and multiple system atrophy
Objective: Here, we compared the prevalence of cerebral microbleeds (CMBs) in patients with parkinsonian disorders, including Parkinson’s diseaseParkinson’s disease (PD) and multiple system atrophy (MSA).…First Report of Clinical Outcomes Resulting from Use of Directional Deep Brain Stimulation in Parkinson’s Disease and Essential Tremor
Objective: To evaluate clinical motor outcomes, the patient´s subjectively perceived benefit and the frequency of the use of directional lead stimulation in subjects with Essential tremor…Demographic and Clinical Characters of Parkinson’s Disease in Tertiary Hospital in Kuwait
Objective: To estimate the prevalence of Idiopathic Parkinson’s disease (PD) within patients attending a movement disorder clinic at tertiary hospital in Kuwait Background: PD is…
- « Previous Page
- 1
- …
- 289
- 290
- 291
- 292
- 293
- …
- 405
- Next Page »